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Purpose: To assess whether individual reader performance with 
digital breast tomosynthesis (DBT) and two-dimensional 
(2D) mammography varies with number of years of expe-
rience or volume of 2D mammograms read.
Materials and 
Methods:
After written informed consent was obtained, 8869 women 
(age range, 29–85 years; mean age, 56 years) were re-
cruited into the TOMMY trial (A Comparison of Tomo-
synthesis with Digital Mammography in the UK National 
Health Service Breast Screening Program), an ethically 
approved, multicenter, multireader, retrospective reading 
study, between July 2011 and March 2013. Each case was 
read prospectively for clinical assessment and to establish 
ground truth. A retrospective reading data set of 7060 
cases was created and randomly allocated for independent 
blinded review of (a) 2D mammograms, (b) DBT images 
and 2D mammograms, and (c) synthetic 2D mammograms 
and DBT images, without access to previous examinations. 
Readers (19 radiologists, three advanced practitioner ra-
diographers, and two breast clinicians) who had 3–25 (me-
dian, 10) years of experience in the U.K. National Health 
Service Breast Screening Program and read 5000–13 000 
(median, 8000) cases per annum were included in this 
study. Specificity was analyzed according to reader type 
and years and volume of experience, and then both speci-
ficity and sensitivity were analyzed by matched inference. 
The median duration of experience (10 years) was used 
as the cutoff point for comparison of reader performance.
Results: Specificity improved with the addition of DBT for all 
readers. This was significant for all staff groups (56% vs 
68% and 49% vs 67% [P , .0001] for radiologists and 
advanced practitioner radiographers, respectively; 46% 
vs 55% [P = .02] for breast clinicians). Sensitivity was 
improved for 19 of 24 (79%) readers and was significantly 
higher for those with less than 10 years of experience 
(91% vs 86%; P = .03) and those with total mammo-
graphic experience of fewer than 80 000 cases (88% vs 
86%; P = .03).
Conclusion: The addition of DBT to conventional 2D screening mam-
mography improved specificity for all readers, but the gain 
in sensitivity was greater for readers with less than 10 
years of experience.
Published under a CC BY-NC-ND 4.0 license.
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groups continued to improve through-
out their careers, although those with-
out fellowship training showed signifi-
cant improvement in the first 3 years 
of clinical experience, whereas those 
with fellowship training achieved desir-
able clinical standards within 1 year. 
Following up on this, Elmore et al (9) 
looked at the characteristics associ-
ated with performance in screening 
mammography. They found wide var-
iability in sensitivity (74.5%–92.3%) 
even among radiologists with similar 
false-positive rates. Fellowship training 
in breast imaging was the only signifi-
cant characteristic associated with im-
proved sensitivity.
A multireader study, conducted in 
the United States, comparing 2D mam-
mography with DBT-2D mammography 
showed improved performance for 
readers with a range of experience, 
measured by recall rate and receiver 
operating characteristic analysis. Raf-
ferty et al (10) reported that diagnostic 
accuracy increased and recall rates for 
noncancerous cases were significantly 
decreased with the addition of DBT. 
Sensitivity increased for 26 of 27 ra-
diologists and was statistically signifi-
cant for 10 of them. However, Wallis 
et al (11) in the United Kingdom re-
ported that the addition of DBT im-
proved performance only of readers 
with less than 10 years of experience 
with 2D screening mammography. A 
recent study (12) in which the authors 
looked at readers with different levels 
of experience with DBT and compared 
their performance with the use of 
2D mammography and that with use 
of DBT-2D mammography found that 
readers of all levels of DBT experience 
and an 11% reduction in recall rates. 
However, the results were not consis-
tent throughout the 13 U.S. sites that 
participated in the study; some sites 
showed an increase in recall rates.
It is not clear whether the addition 
of DBT to standard 2D mammography 
will improve the diagnostic perfor-
mance of all readers. Evidence from 
reader performance studies in 2D mam-
mography suggests that the number of 
years of experience and the number 
of screening mammograms read per 
year affect diagnostic accuracy. In an 
Australian study, Rawashdeh et al (4) 
reported better performance in read-
ing 2D mammograms for readers with 
high volumes (5000 per annum) com-
pared with readers with low volumes 
and fewer years of experience. A U.S. 
study (5) compared the diagnostic per-
formance of readers with the volume 
of mammograms read and the number 
of years reading mammograms; the re-
sults showed that readers reading fewer 
than 5000 mammograms per annum 
had the highest median recall rate. In 
the United States, readers must read at 
least 960 mammograms every 2 years 
(6), whereas in the United Kingdom, 
readers in the National Health Service 
Breast Screening Program must read 
at least 5000 mammograms per annum 
and undergo annual performance, or 
PERFORMS, testing (7).
The issue of training of radiologists 
in breast imaging has been raised in 
two U.S. studies. Miglioretti et al (8) 
compared the sensitivity and specific-
ity of screening mammography among 
fellowship-trained and nonfellowship-
trained radiologists during the course 
of their careers. They found that both 
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Advances in Knowledge
 n The addition of digital breast 
tomosynthesis (DBT) to two-
dimensional (2D) mammography 
shows greater improvement in 
sensitivity for readers with less 
than 10 years of experience (91% 
vs 86%; P = .03) or for those 
who have read fewer than 80 000 
cases (88% vs 86%; P = .03).
 n With the addition of DBT to 2D 
mammography, specificity was 
improved for all readers regard-
less of length of mammographic 
reading experience (66% vs 55% 
[P , .0001] for those with 
,80 000 reads; 67% vs 53% [P 
, .0001] for those with 80 000 
reads).
 n The improvement in specificity 
was significant for radiologists 
and advanced practitioner 
radiographers (P , .0001 for 
both groups) and breast clini-
cians (P = .02).
 n Readers with less experience 
tended to find more asymmetries 
and distortions with the addition 
of DBT to 2D mammography 
than with 2D mammography 
alone (87% vs 78%), but the dif-
ference was not statistically sig-
nificant (P = .1).
Implications for Patient Care
 n The addition of DBT to 2D mam-
mography will result in improved 
cancer detection, especially when 
cases are read by less experi-
enced readers.
 n The addition of DBT to 2D mam-
mography will result in fewer un-
necessary recalls when cases are 
read by readers of all levels of 
experience.
The addition of digital breast tomo-synthesis (DBT) to two-dimension-al (2D) mammography improves 
specificity and sensitivity in breast can-
cer screening. The Oslo Tomosynthesis 
Screening Trial investigators (1) report-
ed a 27% increase in overall cancer de-
tection rate and an estimated 15% de-
crease in false-positive recall rate with 
the addition of DBT. The Screening 
with Tomosynthesis or standard Mam-
mography trial (2) showed a similar 
improvement in cancer detection, with 
an estimated 17.2% decrease in recall 
rate. Friedewald and colleagues’ recent 
retrospective time series analysis (3), 
comparing performance before and af-
ter the introduction of DBT to standard 
2D screening mammography, reported 
a 29% increase in cancer detection rate 
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Five readers participated only in 
prospective reading (four radiologists 
and one advanced practitioner), and 
two retrospective readers (both radiol-
ogists) were excluded because they had 
read fewer than 200 cases in each arm. 
This left 24 readers (19 radiologists, 
three advanced practitioner radiogra-
phers, and two breast clinicians) to be 
included in the analysis. Images were 
viewed on workstations (SecurView 
DW, Hologic) optimized to read both 
2D mammograms and DBT images.
Retrospective Reading Study
Each case was read by three different 
readers from three different centers: 
one using 2D mammography alone, 
one using DBT-2D mammography, and 
another using DBT–synthetic 2D mam-
mography. A randomization program 
managed by Cambridge Clinical Tri-
als Unit assigned weekly reading sets, 
comprising a mix of normal, benign, 
and cancer cases. Cases were randomly 
selected from the study data set to be 
distributed among readers and cen-
ters to minimize bias. Each reading set 
comprised approximately 40 cases per 
reader per week. Readers were blinded 
to the outcome status of each case, did 
not review any cases that originated 
from their own center, and read cases 
independently without access to prior 
examinations. A decision to recall the 
case was made, and the location, size, 
and type of any suspicious abnormality 
were recorded along with a five-point 
suspicion score (1 = normal, 2 = be-
nign; 3 = probably benign, 4 = probably 
malignant, and 5 = malignant).
Statistical Analysis
It was not possible to identify individ-
ual reader opinion for family history 
cases because of the manner in which 
the prospective data were collected, so 
we used data from the 6020 assessment 
cases (of which 1158 were cancers). Of 
these, for the 24 readers who read at 
least 200 cases in both the 2D mam-
mography and DBT-2D mammography 
arms of the TOMMY trial, we had 2D 
mammography reading and experience 
data on 5888 cases (1141 cancers). 
We had the corresponding DBT-2D 
in six U.K. National Health Service 
Breast Screening Program centers 
from 8869 women (age range, 29–85 
years; mean age, 56 years) recalled to 
the assessment clinic for a mammo-
graphic abnormality found at routine 
2D screening mammography. Screen-
ing cases were read with 2D mammog-
raphy alone by two readers and were 
recalled for assessment if both readers 
found an abnormality. When readers 
disagreed, the cases were subjected 
to further discussion and the decision 
to recall was made on the basis of a 
consensus opinion. Women younger 
than 50 years with a family history 
of breast cancer and who underwent 
annual mammographic screening were 
also included in the main trial but were 
not included in this analysis to avoid 
further complexity due to case hetero-
geneity. For details of family history 
cases, see Gilbert et al (14). Patients 
with breast implants, those who were 
pregnant, and those unable to give 
written informed consent were ex-
cluded. Only one case per woman was 
included in the study (14).
Image Acquisition
Participants underwent standard two-
view 2D mammography of both breasts 
and two-view DBT imaging as a single 
procedure at the same breast compres-
sion with a digital mammography unit 
(Selenia Dimensions; Hologic, Bedford, 
Mass).
Readers
TOMMY trial readers were radiolo-
gists (n = 25), advanced practitioner 
radiographers (n = 4), or breast cli-
nicians (n = 2). Readers had 3–25 
(median, 10) years of mammographic 
reading experience in the U.K. Breast 
Screening Program, reading between 
5000 and 13 000 (median, 8000) ex-
aminations each year (Table 1). 
Each reader attended an intensive 
1-day DBT workshop and read a test 
set of 80 cases (14). All readers par-
ticipated in the prospective data col-
lection and gained experience in DBT 
by reviewing more than 100 DBT cases 
at their own center before they started 
the retrospective reading study.
performed similarly with DBT-2D 
mammography. However, the authors 
of this study did not take into account 
the readers’ experience in background 
2D mammography. Another study of 
eight radiologists with 3–13 years of 
mammographic screening experience 
showed that most readers achieved an 
improved cancer detection rate and/
or a decreased false-positive rate, but 
there was no correlation with experi-
ence (13).
There is a need to establish 
whether the addition of DBT is equally 
effective in improving performance of 
readers with different mammographic 
experience. In this study we assessed 
whether the improved reader perfor-
mance seen overall with the addition of 
DBT to 2D mammography (14,15) var-
ies with reader experience in reading 
2D mammograms.
Materials and Methods
Support for this study was given by Ho-
logic (Bedford, Mass), which created 
synthetic 2D images for the reading 
study. The authors had control of all 
data in the study and the information 
submitted for publication. Scotland A 
Research Ethics Committee approved 
the study, and women gave written in-
formed consent to participate in the 
TOMMY trial (A Comparison of Tomo-
synthesis with Digital Mammography, 
in the U.K. National Health Service 
Breast Screening Programme [14]).
Results from the 7060 cases in the 
reading data set have been reported 
previously (15). That prior article was 
an investigation of the sensitivity and 
specificity of DBT for detecting breast 
cancer subgroups, whereas in our 
study, we analyzed individual reader 
performance according to reader type 
and years and volume of experience.
Study Design and Participants
The TOMMY trial was a retrospective 
reading study designed to compare the 
diagnostic performance of 2D mam-
mography with that of DBT-2D mam-
mography and of DBT synthetic 2D 
mammography. Data were collected 
between July 2011 and March 2013 
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mammography data for 5857 cases 
(1130 cancers). We did not analyze 
data from synthetic 2D mammographic 
images to assess reader performance 
as part of this study. For the purposes 
of this study, a true-positive case was 
one for which cancer was proven his-
tologically by means of surgery or core 
biopsy. A true-negative case was one 
Table 1
Summary of Reader Experience
Site/Reader Code Reader Type* Years Reading Mammograms Mammograms per Year
Years Reading Digital  
Mammograms
Site 1
 1† 1 6 7000 2
 2 1 17 6000 4
 3 1 11 6000 5
 4 1 4 6000 4
 5† 1 15 6000 4
Site 2
 6‡ 1 3 10 000 3
 7† 1 15 8000 12
 8 1 4 10 000 4
 9 1 4 8000 4
 10† 2 8 5147 8
Site 3
 11 1 18 12 000 2
 12 2 10 10 000 1
 13 1 25 5000 5
 14 2 7 13 000 1
 15 1 10 6000 3
Site 4
 16 1 3.5 6000 3
 17 1 10 7000 2
 18 1 20 8000 3
 19 3 7 10 000 2
 20 1 18 10 000 1
Site 5
 21 1 17 9000 7
 22 1 5 7000 5
 23 1 22 7000 2
 24 1 24 10 000 7
 25 3 6 7000 6
Site 6
 26‡ 1 25 13 994 2
 27† 1 8 6549 2
 28 1 6 8430 2
 29 1 23 8061 2
 30 1 3 8525 2
 31 2 10 8000 2
* Reader type: 1 = consultant radiologist, 2 = advanced practitioner radiographer, 3 = breast clinician.
† Readers who only contributed to prospective reading and did not participate in the retrospective reading study.
‡ Readers who were excluded from analysis for insufficient retrospective reads.
for which no cancer was found after a 
3-year follow-up period.
We calculated sensitivities and 
specificities separately for readers be-
low and above the median for years of 
experience, volume of mammograms 
read per year, and total experience 
(the product of years of experience 
and mammograms read per year). 
Formal significance testing in sub-
groups of experience to compare 2D 
mammography with DBT-2D mam-
mography was performed by using the 
method of Duffy et al (16) to combine 
matched and unmatched data. This 
enabled us, for any given experience 
subgroup, to use all of the data rather 
than only data from cases for which 
both the 2D mammography and DBT-
2D mammography readers were in the 
same subgroup. Thus, for example, 
for analysis of sensitivity to cancer for 
readers having a total experience of 
fewer than 80 000 mammograms (the 
median total experience), we were 
able to use all 612 cancers for which 
the 2D mammography readers were 
in this subgroup and all 553 cases 
for which the DBT-2D mammography 
readers had this experience, rather 
than only the 264 cases for which 
both 2D mammography and DBT-
2D mammography readers had read 
fewer than 80 000 mammograms in 
their career. We examined the ra-
diologic features of lesions that were 
detected with DBT-2D mammography 
compared with 2D mammography 
alone and related this to the level of 
experience of the reader. In particu-
lar, we calculated sensitivity within 
the three lesser-experience subgroups 
by dominant radiologic feature.
For formal comparison within staff 
categories, we carried out the same 
formal analysis as for the reader expe-
rience subgroup, with one exception. 
We performed unmatched analysis for 
advanced practice radiographers and 
breast clinicians by using conventional 
x2 tests, because only four cancers were 
read by both advanced practice radiog-
raphers and four were read by both 
breast clinicians. Statistical analysis 
was performed by using software (Stata 
version 10.0; Stata Corp, College Sta-
tion, Texas). We interpreted P values 
less than .05 as indicating a significant 
difference.
Results
The characteristics of the study popula-
tion are shown in Table 2. Of the 5888 
cases in the 2D mammography arm, 
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Table 2
Participant Characteristics
Characteristic
Assessment Cases
No. Randomized*
No. of 
Cancers*
Age range
 ,40 y 3 (,1) 1 (,1)
 40–49 y 340 (6) 27 (2)
 50–59 y 3568 (59) 462 (40)
 60–69 y 1714 (29) 519 (45)
 70 y 364 (6) 141 (12)
 Not known 31 9
Breast density 
 0%–24% 1636 (27) 378 (33)
 25%–49% 2556 (43) 439 (38)
 50%–74% 1376 (23) 271 (24)
 75%–100% 396 (7) 63 (5)
 Not known 56 8
Cancer type
 Invasive ductal (with or without 
DCIS)
… 788 (68)
 Invasive lobular (with or without 
DCIS)
… 109 (9)
 Invasive other (with or without 
DCIS)
… 59 (5)
 DCIS … 203 (18)
Cancer size 
 Invasive cancers
  1–5 mm … 73 (8)
  6–10 mm … 243 (26)
  11–20 mm … 434 (46)
  21–50 mm … 183 (19)
  .50 mm … 10 (1)
  Unknown … 13
 DCIS
  1–5 mm … 30 (15)
  6–10 mm … 30 (15)
  11–20 mm … 47 (24)
  21–50 mm … 78 (39)
  .50 mm … 15 (7)
  Unknown … 3
Cancer grade
 Invasive cancers
  1 … 242 (26)
  2 … 504 (54)
  3 … 180 (20)
  Unknown … 30
 DCIS
  Low … 10 (8)
  Intermediate … 31 (22)
  High … 97 (70)
  Unknown … 65
Table 2 (continues)
4720 (80%) were read by radiologists, 
654 (11%) by advanced practice radiog-
raphers, and 514 (9%) by breast clini-
cians. The corresponding numbers in 
the DBT-2D mammography arm were 
4608 (79%), 704 (13%), and 505 (8%), 
respectively. The median number of 
years of experience was 10 (interquar-
tile range, 5–18) in both arms. Median 
number of mammograms read per 
year was 8000 (interquartile range, 
6000–10 000) in both groups. Median 
total lifetime mammograms read (the 
product of years of experience and 
mammograms per year) were 70 000 
(interquartile range, 40 000–153 000) in 
the 2D mammography arm and 80 000 
(interquartile range, 40 000–153 000) in 
the DBT-2D mammography arm.
Table 3 shows the cases and can-
cers read, plus estimates of sensitiv-
ity and specificity for each individual 
reader, for 2D mammography and 
DBT-2D mammography. Figure 1 
shows the corresponding sensitiv-
ities and specificities plotted for each 
reader. The upward gradient of most 
lines illustrates how the addition of 
DBT improved both sensitivity and 
specificity. Specificity was improved 
for all readers and sensitivity was im-
proved for 19 of 24 (79%) readers. For 
Characteristic
Assessment Cases
No. Randomized*
No. of 
Cancers*
Lymph node status (invasive cancers 
only)
 Normal … 514 (58)
 ,4 nodes positive … 292 (33)
 4 nodes positive … 77 (9)
 Unknown … 73
Dominant radiologic feature
 Circumscribed mass 1814 (30) 145 (13)
 Spiculated mass 712 (12) 508 (44)
 Microcalcification 1006 (17) 282 (24)
 Distortion 514 (8) 109 (9)
 Asymmetric density 1837 (31) 107 (9)
 None 137 (2) 7 (1)
Note.—DCIS = ductal carcinoma in situ.
* Percentages have been reported for known data. Data in parentheses are percentages.
Table 2 (continued)
Participant Characteristics
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three readers, sensitivity was reduced 
by more than 1% with the addition of 
DBT. All three were experienced ra-
diologists with more than 15 years of 
experience and with cumulative expe-
rience of reading more than 100 000 
mammograms.
Also shown in Table 3 are the dif-
ferences in sensitivity and specificity 
for individual readers, with 95% confi-
dence intervals. The positive estimates 
again illustrate the improvement of both 
measures with the addition of DBT. This 
was generally statistically significant only 
for specificity, probably because of the 
relatively small number of cancer cases 
read by any individual reader.
Table 4 shows estimates of sensi-
tivity and specificity according to the 
three experience measures and staff 
Table 3
Assessment Cases Read, Cancers, Sensitivity, and Specificity for 2D Mammography and DBT-2D Mammography according to 
Individual Reader
Reader Code
No. of Assessment Cases Read* No. of Cases Marked for Recall* Sensitivity (%) Specificity (%) Sensitivity Difference 
(%)†
Specificity Difference 
(%)†2D DBT-2D 2D DBT-2D 2D DBT-2D 2D DBT-2D
2 253 (56) 307 (75) 86 (39) 106 (53) 70 71 76 77 1 (215, 17) 1 (28, 10)
3 254 (61) 239 (42) 142 (57) 109 (40) 93 95 56 65 2 (28, 12) 9 (21, 19)
4 318 (73) 275 (51) 136 (53) 106 (43) 73 84 66 72 11 (24, 26) 6 (23, 14)
8 447 (74) 305 (71) 239 (66) 119 (65) 89 92 54 77 3 (27, 13) 23 (15, 31)
9 235 (43) 223 (53) 111 (33) 90 (45) 77 85 59 74 8 (28, 24) 14 (4, 24)
11 230 (37) 263 (44) 114 (30) 119 (41) 81 93 56 64 12 (23, 27) 8 (22, 18)
12 229 (48) 259 (53) 135 (43) 135 (49) 90 94 49 58 4 (27, 15) 9 (21, 20)
13 218 (42) 245 (51) 141 (38) 93 (43) 90 84 41 74 26 (220, 8) 33 (23, 43)
14 215 (51) 257 (46) 133 (43) 101 (41) 84 89 45 72 5 (29, 19) 26 (16, 37)
15 243 (29) 240 (40) 142 (27) 112 (38) 93 95 46 63 2 (210, 14) 17 (7, 27)
16 248 (51) 184 (38) 135 (46) 96 (35) 90 92 55 58 2 (210, 14) 3 (28, 14)
17 195 (29) 222 (24) 113 (28) 121 (24) 97 100 49 51 3 (24, 10) 2 (29, 13)
18 264 (54) 314 (57) 156 (51) 151 (52) 94 91 50 61 23 (213, 7) 11 (2, 21)
19 249 (42) 263 (54) 165 (41) 163 (54) 98 100 40 48 2 (23, 7) 8 (22, 18)
20 210 (37) 213 (52) 149 (36) 136 (49) 97 94 35 46 23 (212, 6) 11 (0, 22)
21 249 (36) 257 (45) 138 (32) 118 (41) 89 91 50 64 2 (212, 16) 13 (4, 23)
22 284 (63) 300 (57) 157 (57) 122 (53) 90 93 55 72 3 (27, 13) 17 (8, 26)
23 191 (37) 171 (31) 87 (33) 71 (28) 89 90 65 69 1 (214, 16) 4 (27, 16)
24 250 (50) 209 (35) 138 (43) 101 (33) 86 94 53 61 8 (25, 21) 8 (22, 19)
25 265 (56) 242 (42) 151 (51) 118 (41) 91 98 52 62 7 (22, 16) 9 (21, 19)
28 214 (51) 212 (37) 107 (47) 73 (34) 92 92 63 78 0 (212, 12) 14 (4, 25)
29 209 (42) 223 (45) 89 (31) 65 (34) 74 76 65 83 2 (217, 21) 17 (8, 27)
30 208 (40) 206 (44) 90 (33) 81 (37) 83 84 66 73 1 (215, 17) 7 (24, 17)
31 210 (39) 228 (43) 114 (34) 89 (37) 87 86 53 72 21 (216, 14) 19 (8, 29)
Note.—2D = 2D mammography.
* Data in parentheses are number of cancers.
† Data in parentheses are 95% confidence intervals.
Figure 1
Figure 1: Graph 
shows combined change 
in sensitivity and spec-
ificity with the addition 
of DBT according to 
individual reader. An 
upward gradient from 
left to right indicates 
that both sensitivity and 
specificity are improved 
with DBT for that reader. 
Lines with a right-to-left 
upward gradient indicate 
increase in specificity but 
decrease in sensitivity 
for that reader. 2D = 2D 
mammography
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Table 4
Sensitivity and Specificity according to Reader Experience and Staff Category
Variable No. of Readers
2D Mammography DBT-2D Mammography
Sensitivity (%) Specificity (%) Sensitivity Specificity 
Years of experience
 ,10 10 86 (470/544) 55 (1185/2139) 91 (448/493) 69 (1353/1974)
 10 14 88 (534/609) 53 (1392/2615) 88 (571/647) 65 (1835/2817)
Mammograms per year
 ,8000 10 86 (429/497) 56 (1111/1972) 88 (398/451) 67 (1318/1974)
 8000 14 88 (575/656) 53 (1466/2782) 90 (621/689) 66 (1870/2817)
Total experience
 ,80 000 12 88 (539/612) 55 (1399/2548) 92 (509/553) 66 (1557/2358)
 80 000 12 86 (465/541) 53 (1178/2206) 87 (510/587) 67 (1631/2433)
Staff category
 Radiologist 19 86 (780/905) 56 (2125/3815) 88 (788/892) 68 (2515/3716)
 Radiographer 3 87 (120/138) 49 (254/516) 89 (127/142) 67 (404/602)
 Breast clinician 2 94 (92/98) 46 (192/416) 99 (95/96) 55 (223/409)
Note.—Data in parentheses are numerators and denominators.
category. For all subgroups, specific-
ity for DBT-2D mammography was 
significantly higher (P , .0001 for ra-
diologists and radiographers; P = .02 
for breast clinicians). Sensitivity was 
significantly higher for DBT-2D mam-
mography among those with less than 
10 years of experience in reading mam-
mograms (P = .03), for those with a 
total mammogram experience of fewer 
than 80 000 examinations (P = .03), and 
for radiologists (P = .03). There was 
suggestive evidence of higher sensitivity 
for breast clinicians (P = .1). No other 
significant or substantial nonsignificant 
differences were observed with respect 
to sensitivity.
As we noted previously, to better 
understand the sensitivity difference 
in those with less experience, we cal-
culated sensitivity within the three 
lesser-experience subgroups according 
to dominant radiologic feature (Fig 2). 
Although no significant differences in 
sensitivity were observed in these small 
subgroups, the improvement conferred 
by DBT-2D mammography in readers 
with less than 10 years of experience 
was most striking where the dominant 
radiologic feature was asymmetric den-
sity or distortion (87% vs 78%).
Table 5 shows sensitivity according 
to imaging modality and years of reader 
experience for subgroups categorized 
by patient age, visually assessed breast 
density, histologic type of tumor, tumor 
size, and tumor grade. With 2D mam-
mograms only, readers with less than 
10 years of experience had lower sensi-
tivity than did more experienced readers 
for patients younger than age 55 years, 
less than or equal to 50% density, inva-
sive ductal carcinoma, invasive tumors 
of 10 mm or larger, and invasive grade 
Figure 2
Figure 2: Bar graph shows sensitivity according to dominant radiologic feature for readers with less experi-
ence. 3D = three dimensional.
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A strength of this study was that it 
was a very large reader study and in-
cluded a large number of high-volume 
readers with a wide range of years of 
experience. The patients with cancer 
in this study were representative of 
those seen in the U.K. national Breast 
Screening Program, with similar ra-
diologic feature distribution and type, 
grade, and size of cancer (17). A fur-
ther strength was that cases were ran-
domly allocated to the readers.
Weaknesses included the retro-
spective nature of the study. Therefore, 
readers knew that their decisions had 
no clinical implications, which may have 
resulted in them having less concern re-
garding missing a cancer. In addition, 
this was a highly enriched data set be-
cause most patients were those recalled 
to assessment as a result of a mammo-
graphic abnormality; therefore, the ra-
tio of cancer cases to normal cases was 
higher than would be encountered in 
population screening and may not rep-
resent results obtained in a screening 
environment. A further weakness was 
that there were insufficient cancers to 
show an improvement in sensitivity in 
individual readers. Few cancers were 
detected with DBT alone because of 
the way the cases were collected; this 
introduced potential bias of increased 
specificity with DBT compared with 
that of 2D mammography. This could 
have resulted in overestimation of the 
true effect of the addition of DBT on 
specificity. The study design also meant 
that most patients with cancers were 
recalled after 2D screening mammogra-
phy, and therefore, their cancers would 
have been visible at 2D mammography. 
This made it difficult to show increased 
sensitivity with the addition of DBT, 
particularly for experienced readers, 
and sensitivity with DBT was proba-
bly underestimated as a result of this 
method of data collection. In addition, 
because most patients were recruit-
ed from assessment clinics, this may 
have introduced a bias in the reader’s 
decision to recall; that, in turn, would 
result in an increased recall rate, which 
would have affected sensitivity and spec-
ificity. Another limitation of the study 
was that readers did not have access to 
We also have demonstrated a non-
significant improvement in sensitivity for 
80% of readers and a significant increase 
in sensitivity for readers with less than 
10 years of experience with screening 
mammography. There was suggestive 
but nonsignificant evidence that the in-
creased sensitivity of DBT-2D mammog-
raphy for readers with lesser experience 
was largely due to distortions and asym-
metric density as the main radiologic 
feature in patients. For example, for 
readers with less than 10 years of expe-
rience, when the main radiologic feature 
was distortion or asymmetry, sensitivity 
was 78% for 2D mammography versus 
87% for DBT-2D mammography. These 
radiologic features are often subtle and 
are frequently missed, particularly by 
inexperienced mammogram readers. It 
is encouraging that DBT is especially 
useful for identification of these difficult 
features. There were no other major 
observations with respect to radiologic 
features. The lack of significant improve-
ment in sensitivity overall (from 87% to 
89%) in this study may be because the 
addition of DBT had minimal effect on 
the performance of this group of experi-
enced, high-volume readers.
1–2 tumors, but these differences were 
not statistically significant. For the less 
experienced readers, sensitivity was sig-
nificantly improved with the addition of 
DBT for patients younger than 55 years 
(P = .048) and in tumors greater than 
or equal to 10 mm (P = .034). No other 
significant differences in sensitivity were 
observed between less and more experi-
enced readers or between 2D mammog-
raphy and DBT-2D mammography.
Discussion
The results of our study have shown 
a clear improvement in specificity for 
each individual reader. We also have 
demonstrated that the addition of DBT 
has a greater benefit in sensitivity for 
less experienced readers.
The improvement in specificity 
varied between 1% and 33% and was 
not related to volume of mammograms 
read each year or number of years of 
experience. In clinical practice, reduc-
tions in recall rate with the addition of 
DBT are also likely to vary according 
to background recall rate and recall/
arbitration policy, as well as reader-to-
reader variation.
Table 5
Sensitivity according to Imaging Modality and Years of Experience in Subgroups of 
Age; Breast Density; and Tumor Type, Size, and Grade
Variable
,10 Years of Experience 10 Years of Experience
2D Mammography
DBT-2D 
Mammography 2D Mammography
DBT-2D 
Mammography 
Age
 ,55 y 83 (96/115) 93 (99/106) 91 (114/125) 88 (115/131)
 55 y 87 (374/429) 90 (349/387) 87 (420/484) 88 (456/516)
Breast density (visual)
 ,50% 87 (327/375) 90 (322/356) 88 (387/438) 88 (394/449)
 50% 85 (143/169) 92 (126/137) 86 (147/171) 89 (177/198)
Tumor type
 Invasive ductal 86 (309/359) 92 (309/337) 88 (373/425) 89 (391/437)
 Other 87 (161/185) 89 (139/156) 88 (161/184) 86 (180/210)
Invasive tumor size
 10 mm 84 (130/154) 87 (111/128) 87 (149/172) 85 (163/192)
 .10 mm 88 (260/294) 93 (248/266) 88 (286/325) 92 (320/346)
Invasive tumor grade
 1–2 85 (309/363) 90 (276/305) 87 (327/374) 90 (380/421)
 3 96 (72/75) 92 (72/78) 87 (95/109) 88 (92/104)
Note.—Data are percentages and numbers in parentheses are numerators and denominators.
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Relatively small numbers of cancer 
cases were read by breast clinicians 
because we had only two breast clini-
cian readers in our study. Thus, the 
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in sensitivity for this category of staff 
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As a result, true standard errors may 
have been larger than estimated and 
true significance levels may have been 
less extreme than estimated. However, 
the inaccuracy was likely to have been 
small within subgroups of readers ac-
cording to experience.
We have demonstrated that the ad-
dition of DBT substantially and signif-
icantly improves specificity regardless 
of reader experience. The potential of 
DBT to reduce the number of false-
positive recalls will be of considerable 
importance to screening programs, 
because this has been identified as a 
key factor deterring women from un-
dergoing breast screening (18). Before 
DBT can be introduced into screening 
practice, the logistics of doing so must 
be considered. In particular, the effect 
of longer reading times on clinic work-
flow needs assessment. Reading times 
have been reported as being doubled 
with use of DBT, with a reading time of 
91 seconds for DBT-2D mammograms 
compared with 45 seconds for 2D 
mammograms alone in a screening set-
ting (1). However, this could be reason-
able if recall rates are decreased and 
unnecessary diagnostic assessments 
are avoided (19). Cost implications and 
space required for data storage of DBT 
images are other areas that have been 
somewhat overlooked. Individual read-
ing time varies considerably, and it is 
not known whether this is related to 
cancer detection.
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